What are Whitehawk Therapeutics, Inc. Common Stock's total assets?

Whitehawk Therapeutics, Inc. Common Stock (WHWK) holds $127.2M in total assets, down 45.6% year over year.

How much cash does Whitehawk Therapeutics, Inc. Common Stock have?

Whitehawk Therapeutics, Inc. Common Stock holds $34.8M in cash and equivalents.

Can Whitehawk Therapeutics, Inc. Common Stock cover its short-term obligations?

Its current ratio is 11.36 — current assets exceed current liabilities.

Where does Whitehawk Therapeutics, Inc. Common Stock's balance sheet data come from?

Every line is extracted from Whitehawk Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Whitehawk Therapeutics, Inc. Common Stock WHWK Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$34.79M-84.7%	$37.57M+31.0%	$37.93M+24.2%	$144.94M+252%	$227.57M+323%
Short-term investments	$88.25M+2,427%	$108.13M+482%	$124.67M+289%	$32.26M-13.8%	$3.49M-89.9%
Accounts receivable, net	$0—	$0-100%	$0-100%	$0-100%	$0-100%
Inventories	-$0—	$0-100%	$0-100%	$0-100%	$0-100%
Prepaid expenses and other current assets	$2.51M+61.4%	$3.32M+16.9%	$2.44M-9.3%	$1.47M-39.2%	$1.55M-54.8%
Total current assets	$125.55M-46.0%	$149.01M+143%	$165.04M+113%	$178.67M+92.1%	$232.61M+127%
Property and equipment, net	$2K-92.0%	$3K-100.0%	$4K-99.9%	$9K-99.9%	$25K-99.6%
Other non-current assets	$1.68M+23.3%	$1.81M+29.7%	$1.98M+30.5%	$2.14M+31.5%	$1.36M-21.5%
Total assets	$127.23M-45.6%	$150.83M+114%	$167.02M+94.9%	$180.82M+77.9%	$234M+111%
Accounts payable	$1.75M-52.3%	$917K-57.5%	$1.63M+18.9%	$3.34M+47.4%	$3.66M+18.2%
Accrued expenses	$9.31M+8.1%	$13.6M-7.1%	$8.22M-41.8%	$5.42M-60.6%	$8.62M-18.7%
Total current liabilities	$11.06M-9.9%	$14.52M-15.0%	$9.85M-37.7%	$8.76M-60.5%	$12.27M-38.2%
Total liabilities	$11.06M-9.9%	$14.52M-18.6%	$9.85M-41.5%	$8.76M-61.6%	$12.27M-40.5%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	$4K-100.0%	$4K+100%	$4K-100.0%	$4K-100.0%	$300M0.0%
Additional paid-in capital	$491.63M+2.1%	$489.44M+27.1%	$487.02M+27.1%	$484.31M+27.2%	$481.36M+27.4%
Retained earnings	-$375.44M-44.6%	-$353.25M-6.2%	-$330M-5.0%	-$312.25M-3.5%	-$259.64M+9.6%
Accumulated other comprehensive income (loss)	-$15K-1,600%	$120K+650%	$139K+256%	$9K+133%	$1K+113%
Total stockholders' equity	$116.18M-47.6%	$136.31M+160%	$157.17M+128%	$172.07M+118%	$221.73M+145%
Total liabilities and stockholders' equity	$127.23M-45.6%	$150.83M+114%	$167.02M+94.9%	$180.82M+77.9%	$234M+111%
Deferred Tax Assets and Other Non-Current Assets	$1.68M+23.3%	$1.81M+29.7%	$1.98M+30.5%	$2.14M+31.5%	$1.36M-21.5%
Other non-current assets	$1.68M+23.3%	$1.81M+29.7%	$1.98M+30.5%	$2.14M+31.5%	$1.36M-21.5%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$88.25M+2,427%	$108.13M+482%	$124.67M+289%	$32.26M-13.8%	$3.49M-89.9%
Software and Technology Licenses, Net	$1.68M+23.3%	$1.81M+29.7%	$1.98M+30.5%	$2.14M+31.5%	$1.36M-21.5%
Other Commercial Liabilities	$9.31M+8.1%	$13.6M-7.1%	$8.22M-41.8%	$5.42M-60.6%	$8.62M-18.7%
Accrued Liabilities, Current	$9.31M+8.1%	$13.6M-7.1%	$8.22M-41.8%	$5.42M-60.6%	$8.62M-18.7%
Additional paid-in capital	$491.63M+2.1%	$489.44M+27.1%	$487.02M+27.1%	$484.31M+27.2%	$481.36M+27.4%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$4K0.0%	$4K+100%	$4K+100%	$4K+100%	$4K+100%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Whitehawk Therapeutics, Inc. Common Stock's total assets?: Whitehawk Therapeutics, Inc. Common Stock (WHWK) holds $127.2M in total assets, down 45.6% year over year.
How much cash does Whitehawk Therapeutics, Inc. Common Stock have?: Whitehawk Therapeutics, Inc. Common Stock holds $34.8M in cash and equivalents.
Can Whitehawk Therapeutics, Inc. Common Stock cover its short-term obligations?: Its current ratio is 11.36 — current assets exceed current liabilities.
Where does Whitehawk Therapeutics, Inc. Common Stock's balance sheet data come from?: Every line is extracted from Whitehawk Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.